Olema Pharmaceuticals
OLMA
OLMA
132 hedge funds and large institutions have $248M invested in Olema Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $415M → $248M (-$167M)
49% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 47
79% less call options, than puts
Call options by funds: $27K | Put options by funds: $128K
Holders
132
Holding in Top 10
2
Calls
$27K
Puts
$128K
Top Buyers
| 1 | +$10.3M | |
| 2 | +$2.22M | |
| 3 | +$2.05M | |
| 4 |
Goldman Sachs
New York
|
+$1.35M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$1.22M |
Top Sellers
| 1 | -$9.63M | |
| 2 | -$8.38M | |
| 3 | -$3.81M | |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$3.79M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.73M |
